Abstract |
Immunization with Human Papillomavirus (HPV) L1 virus-like particles or L2 capsid protein elicits neutralizing antibodies that mediate protection. A high-throughput and sensitive in vitro neutralization assay is therefore valuable for prophylactic HPV vaccine studies. Over several hours during infection of the genital tract, virions take on a distinct intermediate conformation, including a required furin cleavage of L2 at its N-terminus. This intermediate is an important target for neutralization by L2-specific antibody, but it is very transiently exposed during in vitro infection of most cell lines resulting in insensitive measurement for L2, but not L1-specific neutralizing antibodies. To model this intermediate, we describe a protocol to generate furin-cleaved HPV pseudovirions (fc-PsV), which deliver an encapsidated reporter plasmid to facilitate infectivity measurements. We also describe a protocol for use of fc-PsV in a high-throughput in vitro neutralization assay for the sensitive measurement of both L1 and L2-specific neutralizing antibodies.
|
Authors | Joshua W Wang, Ken Matsui, Yuanji Pan, Kihyuck Kwak, Shiwen Peng, Troy Kemp, Ligia Pinto, Richard B S Roden |
Journal | Current protocols in microbiology
(Curr Protoc Microbiol)
Vol. 38
Pg. 14B.5.1-26
(Aug 03 2015)
ISSN: 1934-8533 [Electronic] United States |
PMID | 26237105
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | Copyright © 2015 John Wiley & Sons, Inc. |
Chemical References |
- Antibodies, Neutralizing
- Antibodies, Viral
- Virosomes
- Furin
|
Topics |
- Antibodies, Neutralizing
(immunology)
- Antibodies, Viral
(immunology)
- Furin
(metabolism)
- High-Throughput Screening Assays
- Humans
- Neutralization Tests
(methods)
- Papillomaviridae
(genetics, immunology)
- Virosomes
(genetics, immunology)
|